In a study by Meijer et al. [153], Elevated PSAP mRNA was significantly associated with shorter progression-free (PFS) survival in patients with estrogen receptor (ER)-positive breast cancer treated with tamoxifen. The gene discussed is ESR1; the disease is breast cancer.